Lipid and lipoprotein profiles in children with familial hypercholesterolaemia: Effects of therapy

European Journal of Pediatrics

Volumn 157, Issue 11, 1998, Pages 912-918

  Hennermann, J B ^a,b   Herwig, J ^a   Marz W ^a   Asskali, F ^a   Bohles H J ^a  

^a GOETHE UNIVERSITY   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Child Familial hypercholesterolaemia; Diet therapy; Drug therapy; Lipoproteins

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN E; CHOLESTEROL; COLESTIPOL; COLESTYRAMINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SITOSTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET THERAPY; DRUG EFFICACY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENETIC RISK; HUMAN; INFANT; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NEWBORN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROGNOSIS;

ADOLESCENT; ADULT; APOLIPOPROTEINS; CHILD; CHILD, PRESCHOOL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; INFANT; INFANT, NEWBORN; LIPIDS; LIPOPROTEINS; MALE; RETROSPECTIVE STUDIES; TRIGLYCERIDES;

EID: 0031734356     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004310050966     Document Type: Article

References (38)

1. American Academy of Pediatrics (1992) Committee on nutrition: statement on cholesterol. Pediatrics 90:469-473
2. American Heart Association. Committee on Atherosclerosis and Hypertension in Childhood of the Council of Cardiovascular Disease in the Young and the Nutrition Committee (1986) Diagnosis and treatment of primary hyperlipidemia in childhood. Circulation 75:1181-1188
3. Assmann G, Schulte H (1986) PROCAM Trial. Panscienta, Hedingen-Zürich
4. Bailleul S, Couderc R, Rossignol C, Fermanian J, Boutouchent F, Farnier M-A, Etienne J (1995) Lipoprotein(a) in childhood: relation with other atherosclerosis risk factors and family history of atherosclerosis. Clin Chem 41:241-245
5. Boerwinkle E, Utermann G (1988) Simultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B, and cholesterol metabolism. Am J Hum Genet 42:104-122
6. Carter GC (1997) Hypercholesterolemia in children. Pediatr Ann 26:122-127
7. Cetta F, Driscoll DJ, Lucas AR, Urevig RL, Huse DM, Eckert SK, Weidman WH (1994) Growth patterns of hyperlipidemic children enrolled in a preventive cardiovascular health clinic. Clin Pediatr 33:588-592
8. Davignon J, Gregg RE, Sing CF (1988) Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8:1-21
9. Eckel W, Wieland H, Heuck CC, Seidel D, Dietrich R, Scheurlen H (1977) Eine zuverlässige und einfache Methode zur Erkennung gefährlicher Formen von Dyslipoproteinämien. Ärztl Lab 4:101-110
10. Enos WF, Holmes RH, Beyer J (1953) Coronary heart disease among United States soldiers killed in action in Korea: preliminary report. JAMA 152:1090-1093
11. Frederickson DS, Lees S (1965) A system for phenotyping hyperlipoproteinemia. Circulation 31:321-327
12. Frederickson DS, Levy RI, Lees RS (1967) Fat transport in lipoprotein - an integrated approach to mechanisms and disorders. N Engl J Med 276:34-42
13. Gofman JW, Lindgren FT, Elliot H (1949) Ultracentrifugal studies of lipoproteins of human serum. J Biol Chem 179:973-979
14. Hatch FT, Lees DM (1968) Practical methods for plasma lipoprotein analyses. Adv Lipid Res 6:1-67
15. Hostetter AL (1995) Screening for dyslipidemia - practice parameter. Am J Clin Pathol 103:380-385
16. Koletzko B, Kupke I, Wendel U (1992) Treatment of hypercholesterolemia in children and adolescents. Acta Paediatr 81:692-685
17. Leung WH, Lau CP, Wong CP (1993) Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients. Lancet 341:1496-1500
18. März W, Cezanne S, Gross W (1991) Phenotyping of apolipoprotein E by immunoblotting in immobilized pH gradient. Electrophoresis 12:59-63
19. März W, Baumstark MW, Scharnagl H, Ruzicka V, Buxbaum S, Herwig J, Pohl T, Russ A, Schaaf L, Berg A, et al (1993) Accumulation of "small dense" low density lipoproteins (LDL) in a homozygous patients with familial defective apolipoprotein B-100 results from heterogenous interaction of LDL subfractions with the LDL receptor. J Clin Invest 92:2922-2933
20. McNamara JJ, Molat MA, Stremple JF, Cutting RT (1971) Coronary artery disease in combat casualties in Vietnam. JAMA 216:1185-1187
21. Miller NE (1987) Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary arteriosclerosis. Am Heart J 113:589-597
22. Murai A, Miyahara T, Fujimoto N, Matsuda M, Kameyama M (1986) Lp(a) lipoprotein as a risk factor for CHD and cerebral infarction. Artherosclerosis 59:199-204
23. Newman WP, Freedman DS, Voors AW, Gard PD, Srinivasan SR, Cresanta JL, Williamson GD, Webber LS, Berenson GS (1986) Relation of serum lipoprotein levels and systolic blood pressure to early artherosclerosis. The Bogalusa Heart Study. N Engl J Med 314:138-144
24. Ose L, Tonstad S (1995) The detection and management of dyslipidemia in children and adolescents. Acta Paediatr 84:1213-1215
25. Rhoads GG, Dahlen G, Berg K, Morton NE, Dannenberg AL (1986) Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA 256:2540-2544
26. Rosengren A, Wilhelmsen L, Eriksson E, Risberg B, Wedel H (1990) Lipoprotein(a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. B M J 301:1248-1251
27. Ruzicka V, März W, Russ A, Groß W (1992) Apolipoprotein B (Arg?-Gln) allele specific polymerase chain reaction: large scale screening of pooled blood samples. J Lipid Res 33:1563-1567
28. Sanchez-Bayle M, Gonzalez-Requejo A, Baeza J, Arnaiz P, Vila S, Asensio J, Ruiz-Jarabo C (1994) Diet therapy for hypercholesterolemia in children and adolescents. Arch Pediatr Adolesc Med 148:28-32
29. Seed M, Doherty E, Stubbs P (1995) Lipoprotein(a): a prothrombotic risk factor for coronary artery disease. J Cardiovasc Risk 2:206-215
30. Small DM, Bond MG, Waugh D, Prack M, Sawyer JK (1984) Physiochemical and histological changes in the arterial wall of nonhuman primates during progression and regression of atherosclerosis. J Clin Invest 73:1590-1605
31. Stein EA (1989) Treatment of familial hypercholesterolemia with drugs in children. Arteriosclerosis 9 (S1):145-151
32. Stein EA, Shapero J, McNerney C, Glueck CJ, Tracy T, Gartside P (1982) Changes in plasma lipid and lipoprotein fractions after alteration in dietary cholesterol, polyunsaturated, saturated, and total fat in free-living normal and hypercholesterolemic children. Am J Clin Nutr 35:1375-1390
33. Tonstad S, Knudtzon J, Sivertsen M, Refsum H, Ose L (1996) Efficacy and safety of cholestyramine therapy in peripubertal and prepubertal children with familial hypercholesterolemia. J Pediatr 129:42-49
34. Tonstadt S, Sivertsen M (1997) Dietary adherence in children with familial hypercholesterolemia. Am J Clin Nutr 65:1018-1026
35. Widhalm K (1987) Paediatric guidelines for lipid reduction. Eur Heart J [Suppl E]:65-70
36. Widhalm K, Genser D (1994) Elevated levels of lipoprotein(a) in children with familial hypercholesterinemia. Wien Klin Wochenschr 106/7:197-200
37. Wilson PWF, Christiansen JC, Andersen KM, Kannel WB (1989) Impact of national guidelines for cholesterol risk factor screening: the Framingham Offspring Study. JAMA 262:41-44
38. Wilson PWF, Myers RH, Larson MG, Ordovas JM, Wolf PA, Schaefer EJ (1994) Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study. JAMA 272:1666-1671